Anissa Cheung US FDA

Anissa Cheung serves as the senior regulatory coordinator in the Division of Viral Products in the Office of Vaccines Review and Research at CBER. She provides oversight on the review activities for the development and licensure of viral vaccines. During the COVID-19 pandemic, she was given oversight to the authorization and subsequent licensure of the SARS-CoV-2 vaccines. She is also an experienced product specialist conducting pre-approval and GMP inspections for viral vaccine manufacturing facilities. She represents the Division Director in meetings and conferences with industry on matters that concerns the regulatory responsibilities of the Division. She participates in the preparation of the written FDA policy guidelines and recommendations for industry.